S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The Small Biotech Scaring Big Pharma (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The Small Biotech Scaring Big Pharma (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The Small Biotech Scaring Big Pharma (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
The Small Biotech Scaring Big Pharma (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:NVOS

Novo Integrated Sciences - NVOS Stock Forecast, Price & News

$0.26
+0.01 (+4.07%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.25
$0.26
50-Day Range
$0.22
$1.12
52-Week Range
$0.21
$3.32
Volume
22,096 shs
Average Volume
88,152 shs
Market Capitalization
$7.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NVOS stock logo

About Novo Integrated Sciences (NASDAQ:NVOS) Stock

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

NVOS Stock News Headlines

Novo Integrated Sciences, Inc. (NVOS)
See More Headlines
Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

NVOS Company Calendar

Today
12/01/2022
Next Earnings (Estimated)
12/13/2022
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Engines & turbines
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NVOS
Fax
N/A
Employees
91
Year Founded
N/A

Profitability

Net Income
$-4,460,000.00
Pretax Margin
-54.79%

Debt

Sales & Book Value

Annual Sales
$9.31 million
Book Value
$1.65 per share

Miscellaneous

Free Float
17,243,000
Market Cap
$7.97 million
Optionable
Not Optionable
Beta
-0.50

Key Executives

  • Mr. Robert Mattacchione (Age 54)
    Chairman & CEO
    Comp: $46.5k
  • Mr. Christopher Mehlin David (Age 63)
    COO, Pres & Director
    Comp: $114.75k
  • Mr. James Zsebok (Age 56)
    Principal Financial Officer
  • Dr. Indrajit Sinha Ph.D.
    Chief Science Officer
  • Mr. David Brien BSc.PT
    BSc.Bio, Sr. VP of Clinical Operations - Eastern Ontario
  • Dr. Joseph M. Chalil FACHE
    M.B.A., M.D., Chief Medical Officer & Chairman of Medical Advisory Board
  • Ms. Emily Mattacchione (Age 41)
    Treasurer













NVOS Stock - Frequently Asked Questions

How have NVOS shares performed in 2022?

Novo Integrated Sciences' stock was trading at $1.40 at the beginning of the year. Since then, NVOS shares have decreased by 81.9% and is now trading at $0.2540.
View the best growth stocks for 2022 here
.

Are investors shorting Novo Integrated Sciences?

Novo Integrated Sciences saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 200 shares, a drop of 99.9% from the October 31st total of 148,300 shares. Based on an average daily trading volume, of 207,900 shares, the days-to-cover ratio is presently 0.0 days.
View Novo Integrated Sciences' Short Interest
.

When is Novo Integrated Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 13th 2022.
View our NVOS earnings forecast
.

What is Novo Integrated Sciences' stock symbol?

Novo Integrated Sciences trades on the NASDAQ under the ticker symbol "NVOS."

How do I buy shares of Novo Integrated Sciences?

Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novo Integrated Sciences' stock price today?

One share of NVOS stock can currently be purchased for approximately $0.25.

How much money does Novo Integrated Sciences make?

Novo Integrated Sciences (NASDAQ:NVOS) has a market capitalization of $7.92 million and generates $9.31 million in revenue each year. The company earns $-4,460,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How can I contact Novo Integrated Sciences?

Novo Integrated Sciences' mailing address is 11120 NE 2ND STREET SUITE 100, BELLEVUE WA, 98004. The official website for the company is novointegrated.com. The company can be reached via phone at (206) 617-9797 or via email at info@novointegrated.com.

This page (NASDAQ:NVOS) was last updated on 12/2/2022 by MarketBeat.com Staff